Devices and methods for fistula formation

Information

  • Patent Grant
  • 10869717
  • Patent Number
    10,869,717
  • Date Filed
    Friday, November 4, 2016
    8 years ago
  • Date Issued
    Tuesday, December 22, 2020
    4 years ago
Abstract
Described here are devices and methods for forming a fistula between two vessels. In some instances, the fistula may be formed between a proximal ulnar artery and a deep ulnar vein. The fistula may be formed using an electrode, and may be formed with a first catheter placed in a first blood vessel and a second catheter placed in a second blood vessel. In some instances, access to the proximal ulnar artery may be achieved through a brachial artery, and access to the deep ulnar vein may be achieved through a brachial vein.
Description
FIELD

The current invention relates to methods for forming a fistula between two blood vessels.


BACKGROUND

A fistula is generally a passageway formed between two internal organs. Forming a fistula between two blood vessels can have one or more beneficial functions. For example, the formation of a fistula between an artery and a vein may provide access to the vasculature for hemodialysis patients. Specifically, forming a fistula between an artery and a vein allows blood to flow quickly between the vessels while bypassing the capillaries. Needles, catheters, or other cannulas may then be inserted into the blood vessels near the fistula to draw blood from the circulatory system, pass it through a dialysis machine, and return it to the body. The quickened flow provided by the fistula may provide for effective hemodialysis. Generally, fistula formation requires the surgical dissection of a target vein, transecting and moving the vein for surgical anastomosis to the artery. These fistulas typically have a primary failure rate (failure before the patient receives dialysis) of about 30-60%, and take between 5 and 12 months before the fistula is usable for dialysis. It may be useful to find improved ways to form a fistula between two blood vessels.


BRIEF SUMMARY

In some variations, the methods described here comprise forming a first fistula between a proximal ulnar artery and a first deep ulnar vein. In some variations, the methods may further comprise endovascularly advancing a distal portion of a first catheter into the first deep ulnar vein. In some of these variations, the first catheter comprises a fistula-forming element, and forming the first fistula between the proximal ulnar artery and the first deep ulnar vein comprises forming the first fistula using the fistula-forming element. The fistula-forming element may be, for example, an electrode. In some of these variations, the methods further comprise moving the electrode away from the first catheter against a vessel wall of the deep ulnar vein, and wherein forming the first fistula between the proximal ulnar artery and the first deep ulnar vein comprises ablating the vessel wall of the deep ulnar vein and a vessel wall of the ulnar artery.


In some variations, the methods described here may further comprise advancing a distal portion of a second catheter into the ulnar artery. In some of these variations, the first and second catheters may each comprise one or more magnets and the method may further comprise aligning the first and second catheters using the one or more magnets of each of the first and second catheters. In some variations, the second catheter may comprise a fistula-forming element, and forming the first fistula between the proximal ulnar artery and the first deep ulnar vein comprises forming the first fistula using the fistula-forming element. The fistula-forming element may be, for example, an electrode. In some of these variations, the method may further comprise moving the electrode away from the second catheter against a vessel wall of the proximal ulnar artery, and forming the first fistula between the proximal ulnar artery and the first deep ulnar vein may comprise ablating the vessel wall of the proximal ulnar artery and a vessel wall of the first deep ulnar vein. In some variations, endovascularly advancing the distal portion of the second catheter into the proximal ulnar artery comprises endovascularly advancing the distal portion of the second catheter into the proximal ulnar artery from a brachial artery. In some of these variations, the method may further comprise creating an access site in the brachial artery and advancing the second catheter into the brachial artery through the access site.


In some variations, endovascularly advancing the distal portion of the first catheter into the first deep ulnar vein comprises endovascularly advancing the distal portion of the first catheter into the first deep ulnar vein from a median cubital vein. In some variations, the method may further comprise forming an access site in a basilic vein, introducing the distal portion of the first catheter into the basilic vein through the access site, and advancing the distal portion of the first catheter into the median cubital vein through the basilic vein.


In some variations, endovascularly advancing the distal portion of the first catheter into the first deep ulnar vein comprises endovascularly advancing the distal portion of the first catheter into the first deep ulnar vein from a median cephalic vein. In some variations, the method may further comprise forming an access site in a cephalic vein, introducing the distal portion of the first catheter into the cephalic vein through the access site, and advancing the distal portion of the first catheter into the median cephalic vein through the cephalic vein. In some variations, endovascularly advancing the distal portion of the first catheter into the first deep ulnar vein comprises endovascularly advancing the distal portion of the first catheter into the first deep ulnar vein from a first brachial vein. In some variations, the method may further comprise forming an access site in the first brachial vein, introducing the distal portion of the first catheter into the first brachial vein through the access site.


In some variations, the methods described here may comprise injecting a radiopaque dye into the proximal ulnar artery. Additionally or alternatively, the methods may comprise forming a second fistula between the proximal ulnar artery and a second deep ulnar vein. Additionally or alternatively, the methods may further comprise cannulating the cephalic vein and/or the basilic vein to provide dialysis access.


In other variations, the methods described here may comprise endovascularly advancing a distal portion of a first catheter through a portion of a basilic vein, a median cubital vein, and into a first deep ulnar vein, endovascularly advancing a distal portion of a second catheter through a portion of a brachial artery and into a ulnar artery, and forming a fistula between the first deep ulnar vein and the ulnar artery. In still variations, the methods described here may comprise endovascularly advancing a distal portion of a first catheter through a portion of a cephalic vein, a median cephalic vein, and into a first deep ulnar vein, endovascularly advancing a distal portion of a second catheter through a portion of a brachial artery and into a ulnar artery, and forming a fistula between the first deep ulnar vein and the ulnar artery. In yet other variations, the methods described here may comprise endovascularly advancing a distal portion of a first catheter through a portion of a first brachial vein and into a first deep ulnar vein, endovascularly advancing a distal portion of a second catheter through a portion of a brachial artery and into a ulnar artery, and forming a fistula between the first deep ulnar vein and the ulnar artery.





BRIEF DESCRIPTION


FIG. 1 is an illustrative depiction of the vascular anatomy of the arm.



FIG. 2 depicts a variation of a catheter system suitable for use with the methods described here.



FIGS. 3A-3C depict an illustrative method as described here.



FIGS. 4A-4C depict a variation of a device described here for forming a fistula.





DETAILED DESCRIPTION

Generally described here are methods for forming one or more fistulas between blood vessels of the arm. The methods described here comprise forming a fistula between an ulnar artery and a deep ulnar vein, as will be described in detail below. The fistula may be formed using one or more catheters, which may be advanced endovascularly into an ulnar artery and/or a deep ulnar vein. In some variations a first catheter may be advanced into the ulnar artery, and a second catheter may be placed into a deep ulnar vein, and the first and second catheters may form a fistula therebetween. Access to the vascular sites may be achieved in a number of ways, such as will be described in more detail below. Accordingly, it may be helpful to briefly describe the anatomy of the vasculature of the arm.



FIG. 1 shows a simplified depiction of the typical vascular anatomy of the arm around the elbow. Specifically, FIG. 1 shows an anterior view of the right arm as would be seen with the palm facing upward. As shown there, the brachial artery (100) extends superficially and distally from the upper arm and sinks deeply into the arm near the elbow joint, where the brachial artery (100) branches into the radial artery (102) and the ulnar artery (104). The upper portion of the ulnar artery (104) is deeply seated within the arm beneath the superficial flexor muscles (not shown), and leads down the ulnar side of the forearm to the wrist. The anterior ulnar recurrent artery (106) and the posterior ulnar recurrent artery (108) branch off of the ulnar artery (104) just below the elbow joint, and these arteries supply blood to the joint and surrounding muscles. Further down the arm (typically just below the radial tuberosity of the radius bone (not shown)), the interosseous artery (109) branches off from the ulnar artery (104) and eventually feeds into the posterior and anterior interosseous arteries.


Also shown in FIG. 1 are the cephalic vein and the basilic vein. The cephalic vein runs along the outer border of the bicep muscle (not shown) continues down into the forearm (the cephalic vein of the upper arm is labeled in FIG. 1 as cephalic vein (110), while the cephalic vein of the lower arm is labeled as cephalic vein (114)). The median cephalic vein (116) joins the cephalic vein (110)/(114) near the elbow joint. The basilic vein runs along the inner side of the bicep muscle and continues into the forearm (the basilic vein of the upper arm is labeled as basilic vein (112), while the basilic vein of the lower arm is labeled as the common ulnar vein (120)). The median cubital vein (118) (in some instances referred to as the median basilic vein) joins the basilic vein (112)/(120) and the common ulnar vein (120) (in some instances, this vein segment is also referred to as the basilic vein of the forearm or forearm basilica vein). The median cubital vein (118) and the median cephalic vein (116) are formed at the branching of the median antebrachial vein (122) (also known as the median vein). Near the branching of the median vein (122) into the median cubital vein (118) and the medial cephalic vein (116), a perforating branch (124) connects these vessels with the deep veins of the arm through the antebrachial fascia (not shown). As shown in FIG. 1, perforating branch (124) communicates with a first deep ulnar vein (126) and a second deep ulnar vein (128). These deep ulnar veins may run substantially parallel on either side of the ulnar artery (104) between the brachial artery (100) and the interosseous artery (109), and may branch away from ulnar artery (104) distal to the interosseous artery (109). Between the brachial artery (100) and the interosseous artery (109), the deep ulnar veins are typically located in close proximity to the ulnar artery, and usually less than 2 mm separate the ulnar artery from the deep ulnar veins. Along the length of the deep ulnar veins, transverse branches (not shown) may occasionally connect the deep ulnar veins. Also shown in FIG. 1 are first (130) and second (132) brachial veins. The brachial veins generally run along the brachial artery (100), and the deep ulnar veins feed into the brachial veins near the elbow joint. Additionally, a pair of radial veins ((144) and (146)) may run along the radial artery, and may feed into one or both of the brachial veins. Also shown in FIG. 1 are first (140) and second (142) interosseous veins, which may branch off from the first (126) and second (128) deep ulnar veins respectively, and which may run substantially parallel to the interosseous artery (109).


As mentioned above, the methods described here comprise forming a fistula between an ulnar artery and a deep ulnar vein. Preferably, the fistula is formed at a site in the proximal ulnar artery. As used herein, the term “proximal ulnar artery” means the ulnar artery between the brachial artery and branch of the interosseous artery. In some variations, the fistula may be formed between an ulnar artery and a deep ulnar vein at a location within about 6 cm from the branch between the brachial artery and the ulnar artery. In some of these variations, the fistula may be formed at a location less than about 4 cm from the branch between the brachial artery and the ulnar artery. Due to their deep anatomic location, the deep ulnar veins are difficult to access surgically, and thus are not desirable target sites for conventional surgical fistula-forming techniques. The deep anatomic location of the deep ulnar veins, however, means that these veins are usually undamaged (e.g., by needle sticks or other trauma), which may optimize fistula longevity. Additionally, because the deep ulnar veins feed into both the cephalic and basilic venous systems, forming a fistula between the ulnar artery and a deep ulnar vein may provide multiple upper-arm cannulation options for dialysis patients. As both of the deep ulnar veins feed into the cephalic and basilic venous systems, either deep ulnar veins may be selected, and in some instances each of the deep ulnar veins may be utilized to form different fistulas.


Generally, the methods described here comprise endovascularly advancing a distal portion of a first catheter into an ulnar artery, endovascularly advancing a distal portion of a second catheter into a first deep ulnar vein, and forming a fistula between the ulnar artery and the first deep ulnar vein. As mentioned above, the fistula is preferably formed between a proximal ulnar artery and a first deep ulnar vein, and thus the methods may comprise endovascularly advancing a distal portion of a first catheter into a proximal ulnar artery, endovascularly advancing a distal portion of a second catheter into a first deep ulnar vein, and forming a fistula between the proximal ulnar artery and the first deep ulnar vein. When catheters are endovascularly advanced into an ulnar artery and/or a deep ulnar vein, access to these vessels may be achieved in any suitable manner, as will be described in more detail below. The first and second catheters may be aligned to position one or more fistula-forming elements (e.g., one or more electrodes, mechanical cutting elements, chemical mechanisms, cryogenic-cautery devices, laser ablation devices, combinations thereof, and the like, as will be described in more detail below) relative to the desired fistula site. One or both of the first and second catheters may be advanced or retracted within their respective blood vessels to axially position the one or more fistula-forming elements relative to the fistula-formation site. One or both of the first and second catheters may be rotated to rotationally position the one or more fistula-forming elements relative to the fistula-formation site (e.g., to direct a fistula-forming element in the ulnar artery toward a deep ulnar vein, to direct a fistula-forming element in a deep ulnar vein toward the ulnar artery, to direct a fistula-forming element in the ulnar artery toward a fistula-forming element in a deep ulnar vein, etc.). The methods described here may comprise using one or more magnets, markers, and/or other alignment elements to assist in positioning the first and/or second catheters, as will be described in more detail below. Once the one or more fistula-forming elements are positioned relative to the fistula-formation site, the fistula-forming elements may be actuated to cut, ablate, or otherwise remove tissue between the ulnar artery and the deep ulnar vein to form a fistula therebetween.


Following activation of the fistula-forming element, one or more steps may be conducted to assess the condition of the fistula. For example, in some variations a radiopaque dye (or other suitable contrast media) may be introduced into the ulnar artery to confirm blood flow into the deep ulnar vein from the ulnar artery following activation of the fistula-forming element. In some of these variations, the first and/or second catheters may be removed from their respective vessels prior to introduction of the radiopaque dye into the ulnar artery. In other variations, the radiopaque dye may be introduced into the ulnar artery through the first catheter. In some variations, formation of the fistula may act to release one or more radiopaque agents from the first and/or second catheters. For example, in some variations, a first catheter advanced into an ulnar artery may comprise a fistula-forming element, and a second catheter advanced into a deep ulnar vein may comprise a balloon housing a radiopaque agent therein. The first and second catheters may be aligned such that activation may form a fistula between the ulnar artery and deep ulnar vein and also punctures the balloon to release the radiopaque agent.


The methods described here may further comprise forming a second fistula between the ulnar artery and a second deep ulnar vein. For example, if a user or physician determines that there is insufficient flow between the ulnar artery and a first deep ulnar vein, a second fistula may be formed between the ulnar artery and a second deep ulnar vein. The second fistula may be formed during the same procedure, or may be formed during a subsequent procedure. The second fistula may be formed using any of the methods described hereinthroughout.


Because the deep ulnar veins feed into both the cephalic and basilic systems, a patient having a fistula between an ulnar artery and a deep ulnar vein can be cannulated using a blood vessel from either system to provide dialysis access. In some variations, the methods described here may comprise allowing a fistula formed between an ulnar artery and a deep ulnar vein to mature (this may take as long as six or more months), and cannulating either the cephalic and basilic systems to provide vascular access. The methods may further comprise assessing the flow through a vein of the cephalic or basilic system, selecting a vein having a flow rate suitable for dialysis access (which is some instances may be approximately 600 ml/min), and cannulating that vein to provide vascular access. In some variations, this may comprise cannulating a portion of the median cubital vein. In some variations, this may comprise cannulating a portion of the cephalic vein. In other variations, this may comprise cannulating a portion of the basilic vein. In some variations, both the cephalic and basilic veins may be cannulated, as will be described in more detail below. In variations where the cephalic vein is cannulated, the methods may further comprise ligating or coil embolizing the median cubital vein to prevent or reduce flow from the fistula into the basilic vein. Conversely, in variations where the basilic vein is cannulated, the methods may comprise ligating or coil embolizing the median cephalic vein to reduce flow from the fistula into the cephalic vein.


In some variations, the methods may further comprise ligating or coil embolizing at least one brachial vein. In these variations, one or both of the brachial veins may be ligated or coil embolized. Restricting flow through the brachial veins may divert flow to cephalic and/or basilic systems, which may improve flow therethrough. In these variations, the brachial vein or veins may be closed off during the same procedure in which the fistula is formed, or may be closed off during a later procedure (e.g., between about four weeks and about eight weeks following formation of the fistula). In some variations, a first brachial vein may be closed off during the fistula-forming procedure, while a second brachial vein may be closed during a subsequent procedure.


It should be appreciated that the methods described here may be used to form a fistula between the ulnar artery and deep ulnar vein that may not require a stent or other connecting structure to maintain patency of the fistula. In some variations, however, the methods described here may further comprise placing a stent, tube, or other structure between the ulnar artery and deep ulnar vein. Additionally, while the methods described immediately above may comprise advancing catheters into both the ulnar artery and a deep ulnar vein, respectively, it should be appreciated that in some variations a fistula may be formed using only a first catheter placed in a deep ulnar vein, or may be formed using only a first catheter placed in the ulnar artery. When a first catheter is placed in the ulnar artery and a second catheter is placed in a deep ulnar vein, either catheter or both catheters may comprise one or more fistula-forming elements. When a first catheter placed in the ulnar artery comprises a fistula-forming element, that fistula-forming element may form the fistula directionally from the ulnar artery into the deep ulnar vein. When a second catheter placed in the ulnar artery comprises a fistula-forming element, that fistula-forming element may form the fistula directionally from the deep ulnar vein into the ulnar artery. When both first and second catheters comprise fistula-forming elements, the fistula may be formed directionally from the deep ulnar vein into the ulnar artery, directionally from the ulnar artery into a deep ulnar vein, or may be formed simultaneously from both the ulnar artery and a deep ulnar vein.


Any suitable catheter or catheters may be used to form the fistulas using the methods described here. The methods described here may use one or more of the devices as described in U.S. patent application Ser. No. 13/298,169, filed on Nov. 16, 2011 and titled “DEVICES AND METHODS FOR FORMING A FISTULA,” which is hereby incorporated by reference in its entirety. In some variations, a fistula may be formed using a first catheter placed in the ulnar artery and a second catheter placed in the deep ulnar vein. FIG. 2 show one variation of a catheter system (200) that may be used to form a fistula between the ulnar artery and a deep ulnar vein. As shown there, system (200) may comprise a first catheter (202) and a second catheter (203). The first catheter (202) may comprise a catheter body (204) and an electrode (206) which may be advanced out of an opening (205) in the catheter body (204). Current may be passed through the electrode (206) to ablate or otherwise remove tissue contacted by the electrode (206). In some variations, the first catheter (202) may comprise an insulating housing (208) (e.g., a ceramic housing or the like) within the catheter body, which may help protect other components of the first catheter (202) from heat that may be generated by the electrode (206) during tissue removal. The electrode (206) may be selectively moved from a position in which the electrode (206) is retained or otherwise held in the catheter body (204) to a position in which the electrode (206) extends away from the catheter body (204) (such as shown in FIG. 2), and electrode (206) may also be selectively moved back to a retracted/low-profile position (either the same or a different position as the previous retracted position) following ablation of tissue. In some variations, the electrode (206) may be biased toward an extended position when not otherwise restrained by the catheter body (204). While a fistula-forming element comprising an electrode (206) is shown in FIG. 2, it should be appreciated that the methods described here may utilize a catheter comprising any suitable fistula-forming element (e.g., one or more electrodes/electrocautery mechanisms, cone or more mechanical cutting mechanisms such as blades, lances, needles, or the like, one or more chemical devices, cryogenic-cautery devices, laser ablation devices, combinations thereof and the like), such as those described in more detail in U.S. patent application Ser. No. 13/298,169, which was previously incorporated by reference in its entirety, and may be operated in any manner as described therein.


While shown in FIG. 2 as having both first (202) and second (203) catheters, system (200) need not comprise two catheters. For example, in variations of the methods described here in which a fistula is formed using a catheter placed only in the ulnar artery or only in a deep ulnar vein, the system (200) may comprise only a first catheter (202). In variations that do have a second catheter (203), the second catheter (203) may have any suitable elements or combination of elements. For example, the second catheter (203) may comprise a catheter body (208) having a recess (210) extending therein. The recess (210) may be coated by an insulating material (not shown), which may act as a backstop to receive and contact the electrode (206) of the first catheter without damaging one or more components of the first catheter (202). Additionally or alternatively, the second catheter (203) may comprise one or more fistula-forming elements, which may be the same as or different from the fistula forming element or elements of the first catheter (202).


The methods described here may utilize one or more catheters comprising one or more alignment elements, which may help to position catheters within the vasculature. For example, in some variations a method may comprise using one or more alignment elements to help bring two or more catheters (and with them, associated blood vessels) in closer approximation. Additionally or alternatively, a method may comprise using one or more alignment elements to position one or more catheters in a specific rotational configuration relative to the blood vessels and/or the other catheters. Additionally or alternatively, a method may comprise using one or more alignment elements to position one or more catheters axially within a blood vessel or blood vessels. For example, one or more alignment elements may be configured to position a fistula-forming element of a catheter relative to the ulnar artery and a deep ulnar vein such that activation of the fistula-forming element directs fistula formation between the two vessels.


In some variations, a catheter may comprise one or more magnetic alignment components. Examples of magnet arrangements for use with the catheters described here may be found in U.S. patent application Ser. No. 13/298,169, which was previously incorporated by reference in its entirety. These magnetic alignment components may be attracted to one or more additional elements (e.g., one or more portions of a second catheter, one or more magnets or other components placed externally from the body) to help position or align the catheter within a vessel. For example, one or more magnets placed outside of the body may interact with the magnetic alignment components of a catheter to help facilitate advancement of the catheter through the vasculature. Additionally or alternatively, one or more magnetic alignment elements of a first catheter may interact with one or more magnetic alignment elements of a second catheter to attract the first and second catheters toward each other, and/or to bias the first and second catheters toward a specific rotational and/or axial alignment.


For example, in the variation of system (200) shown in FIG. 2, each of first (202) and second (203) catheters may comprise a plurality of magnetic alignment elements (212). These magnetic alignment elements (212) may be configured to bias the axial positioning of the first (202) and second (203) catheters such that the opening (205) of the first catheter (202) axially aligns with the recess (210) of the second catheter (203). The magnetic alignment elements (212) may also be configured to bias the rotational positioning of the first (202) and second (203) catheters such that the opening (205) of the first catheter (202) faces toward the recess (210) of the second catheter (203). Accordingly, the magnetic alignment elements (212) may be used to help position the first (202) and second (203) catheters within respective blood vessels such that the electrode (206) may be extended from opening (205) toward recess (210) of the second catheter (203) during fistula formation.


Additionally or alternatively, in some variations, the catheter may comprise one or more shape-changing elements for approximating two or more blood vessels. In these variations, the shape-changing element may have a first configuration during advancement of the catheter through the vasculature. Once the catheter reaches a target location, the shape-changing element may be altered to a second configuration, which may alter the overall shape of the catheter. As the catheter changes shape, the catheter may move or reconfigure one or more portions of the blood vessel, which may help bring that portion or portions of the blood vessel in closer approximation to one or more portions of a second blood vessel. Examples of shape-changing elements for use with the catheters described here may be found in U.S. patent application Ser. No. 13/298,169, which was previously incorporated by reference in its entirety.


Additionally or alternatively, the methods may comprise visualizing one or more markers from one or more catheters during advancement and positioning thereof. In some variations, the marker may be directly visualized. In other variations, the marker may be indirectly visualized (e.g., via ultrasound, fluoroscopy and/or X-ray visualization). Markers may be located anywhere relative to the catheter, e.g., one or more surfaces of the catheter, inside of the catheter. In some variations, one or more portions of the catheter may be made from an echogenic or radiographic material. A marker may be attached to the catheter by any suitable method, for example, by mechanical attachment (e.g., embedded in a portion of the catheter, circumferential circumscription, or the like), adhesive bonding, welding, soldering, combinations thereof or the like. For example, in the variation of system (200) shown above in FIG. 2, each of the first (202) and second (203) catheters may comprise one or more markers (214). These markers (214) may be visualized during advancement and/or position of the first (202) and second (203) catheters to confirm that the catheters are properly positioned within the blood vessels. For example, in variations where a method comprises axially aligning the opening (205) of the first catheter (202) relative to the recess (210) of the second catheter (203) and/or rotationally aligning the opening (205) of the first catheter (202) relative to the recess (210) of the second catheter (203), the method may further comprise visualizing one or more markers (214) of the first (202) and/or second (203) catheters to confirm this positioning.


In some variations, one or more of the catheters may comprise one or more balloons or other expandable structures. These expandable structures may serve one or more functions. In some instances, an expandable structure may help appose an electrode surface (or other fistula-forming element) against one or more vessel walls. This apposition may help temporarily flatten or otherwise relocate tissue, and may act to displace blood from the area. Additionally, during fistula formation, the expandable member may continue to urge the fistula forming element against tissue as it is removed from the vessel wall. In some variations, the expandable structure may be configured to help provide apposition between the catheter and a vessel wall, while still allowing for blood flow through the blood vessel. In some instances, one or more expandable structures may help modify or otherwise alter the size or shape of a fistula. In still other instances, the expandable structures may be used to dilate, contract, or otherwise displace a portion of one or more blood vessels. In some of these variations, this displacement may help bring a portion of the blood vessel closer to a skin surface.



FIGS. 3A-3C depict an illustrative method by which the catheter system (200) of FIG. 2 may be used to form a fistula between a first deep ulnar vein and an ulnar artery. The labeling of FIGS. 1 and 2 will be used for common elements and anatomical locations. As shown in FIG. 3A, the method may comprise endovascularly advancing a distal portion of a first catheter (202) into an ulnar artery (104). In the method shown in FIG. 3A, the first catheter (202) may be advanced into the ulnar artery (104) from the brachial artery (100). In some variations, the method may comprise creating an access site (not shown) in the brachial artery (100), and advancing the first catheter (202) into the brachial artery (100) through the access site. It should be appreciated, however, that the first catheter (202) may be advanced into the ulnar artery in any suitable manner, as described in more detail below.


As shown in FIG. 3B, the method may further comprise endovascularly advancing a second catheter (203) into a first deep ulnar vein (126) (it should be appreciated that the second catheter (203) may be advanced into either of the deep ulnar veins (126) or (128)). In the method shown in FIG. 3B, the second catheter (203) may be advanced into the first deep ulnar vein (126) from the perforating branch (124), which may be accessed by advancing the second catheter (203) through the basilic vein (112) and the median cubital vein (118). In some variations, the method may comprise creating an access site (not shown) in the basilic vein (112), and advancing the second catheter (203) into the basilic vein (112) through the access site. It should be appreciated, however, that the second catheter (203) may be advanced into the deep ulnar vein (126) in any suitable manner, as described in more detail below. While the first catheter (202) is shown in FIG. 3A as being advanced into ulnar artery (104) prior to advancement of the second catheter (203) into the deep ulnar vein (126), it should be appreciated that the first (202) and second (203) catheters may be advanced in any order.


Once the distal ends of the first (202) and second (203) catheters have been advanced into the ulnar artery (104) and deep ulnar vein (126), the first (202) and second (203) catheters may be axially positioned relative to one another to align the opening (205) of the first (202) catheter with the recess (210) of the second catheter (203), as shown in FIG. 3C. Additionally, the first (202) and second (203) catheters may be axially positioned relative to the ulnar artery (104) and deep ulnar vein (126) respectively such that the opening (205) of the first catheter (202) and recess (210) of the second catheter (203) are axially aligned with the desired fistula formation site. In some instances, when the opening (205) of the first catheter (202) and recess (210) of the second catheter (203) are axially aligned with the desired fistula formation site (e.g., in a ulnar artery and a deep ulnar vein), the distal tips of the first and second catheters may extend into the ulnar artery (104) and deep ulnar vein (126) distally of the branching of the interosseous artery (109) and the interosseous veins (e.g. the first interosseous vein (140)), such as shown in FIG. 3B. Alternatively, when the opening (205) of the first catheter (202) and recess (210) of the second catheter (203) are axially aligned as discussed above, a distal tip of the first catheter (202) may extend into the interosseous artery (109) and/or the distal tip of the second catheter (203) may extend into an interosseous vein (e.g., first interosseous vein (140)).


Additionally, the first (202) and second (203) catheters may be rotationally aligned such that opening (205) may face the recess (210) of the second catheter (203). As mentioned above, in some variations, the methods may comprise using one or more magnetic alignment elements (212) help achieve the axial or rotational positioning of the first (202) and second (203) catheters. Additionally or alternatively, the positioning of the first (202) and second (203) catheters may be confirmed by visualizing markers (214) of the first and/or second catheters.


Once the first (202) and second (203) catheters are positioned relative to each other and their respective vessels, the electrode (206) may be advanced out of the opening (205) of the first catheter (202) to press the electrode (206) against a vessel wall of the ulnar artery (104). Energy may be delivered to the electrode (206) to cut tissue, which may advance the electrode (206) from the ulnar artery (104), through the wall of the deep ulnar vein (126), and into the deep ulnar vein (126). In some variations, the first catheter (202) comprising the electrode (206) may be placed in the deep ulnar vein (126) and the second catheter (203) may be placed in the ulnar artery (104), such that the electrode (206) may be advanced from the deep ulnar vein (126) into the ulnar artery (104). Once the fistula has been has been formed between the ulnar artery (104) and the deep ulnar vein (126), one or more contrast agents may be passed through the fistula and/or a second fistula may be formed, such as described in more detail above.


It should be appreciated that in some or all of the methods described here, one or more portions of the patient may be immobilized during some all of the steps of the method. For example, when a fistula is formed between two vessels in an arm, one or more portions of the arm (e.g., a wrist, an elbow, or the like) may be immobilized. In some of these variations, a wrist of the patient may be immobilized. When a wrist is immobilized, the wrist may be immobilized prior to creating access to one or more blood vessels. In some of these variations, the wrist may remain immobilized until after formation of the fistula. It should be appreciated that when a portion of the arm is immobilized, the arm may be temporarily released to reposition the arm, if needed.



FIGS. 4A and 4B depict perspective views and 4C depicts a cross-sectional side view of a device (400) which may be used to form a fistula. While the device (400) may be used to form a fistula between two or more vessels as described above, the device (400) may be used to form a fistula between any two vessels, such as described here and in U.S. patent application Ser. No. 13/298,169, which was previously incorporated by reference in its entirety. As shown in FIG. 4A, the device (400) may comprise a first arm (402), a second arm (404), a handle (406), and a fistula-forming element (408). Generally, the first arm (402) and the second arm (404) may be formed from one or more rigid materials (e.g., one or more metals such as stainless steel, one or more plastics, combinations thereof and the like), such that when each arm is positioned in a respective blood vessel, the vessel may substantially conform to the shape of the arm.


In the variation shown in FIGS. 4A-4C, the handle (406) may comprise a connection portion (414) and a grip portion (416). The grip portion (416) may be sized and configured such that it may be held by a user, and may have any suitable dimensions. For example, in some variations the grip portion (416) may have any suitable length (e.g., between about 8 cm and about 25 cm, between about 12 cm and about 20 cm, or the like) and any suitable diameter (e.g., between about 3 cm and about 12 cm, between about 5 cm and about 8 cm, and the like). The connection portion (414) (which may be connected to a distal end of the grip portion (416)) is generally configured to position the first (402) and second (404) arms relative to each other. As shown there, the first arm (402) may be fixedly connected to the connection portion (414) and the second arm (404) may be adjustably connected to the connection portion (414). Specifically, a proximal end of the second arm (414) may comprise a connector (418) having a track (420) (as illustrated in a cross-sectional side view in FIG. 4C), and a knob (422) may connect the connector (418) to the connection portion (414). Specifically, the knob (422) may comprise a pin (424) which may extend through the track (420) and into the connection portion (414). The knob (422) may be rotated in a first direction to lock the connector (418) relative to the connection portion (414), and may be rotated in a second direction to allow the connector (418) to be adjusted relative to the connection portion (414).


When the connector (418) is adjustable relative to the connection portion (414), the track (420) may be rotated and/or slid relative to the pin (424). Rotation of the connector (418) may rotate the second arm (404) relative to the first arm (402), while sliding of the connector (418) may adjust the distance between the second arm (404) and the first arm (402). Accordingly, the position of the second arm (404) may be adjusted to set a specific relation between the first arm (402) and the second arm (404), and the knob (422) may be adjusted to temporarily lock the position of the second arm (404) relative to the first arm (402). When the first arm (402) and the second arm (404) are placed in first and second vessels, respectively, the relative positioning between the first and second arms may also dictate the relative positioning between the first and second vessels.


The fistula-forming element (408) may be any suitable fistula-forming element (e.g., a cutting mechanism, an electrode) as described in more detail above. In the variation shown in FIGS. 4A-4C, the fistula-forming element may comprise a blade (409) connected to the first arm (402). The blade (409) may be rotatable between a low-profile configuration in which the blade (409) is housed within the first arm (402) (as shown in FIG. 4C) and a cutting configuration in which the blade (409) extends from the first arm (402) (as shown in FIG. 4B). As the blade (409) rotates out of the first arm (402), a cutting edge of the blade (409) may cut tissue. In some variations, the blade (409) may also act as an electrode to deliver current to tissue. The blade (409) may be rotated in any suitable manner. In the variation of the device (400) shown in FIGS. 4A-4C, the device (400) may comprise a blade control knob (410). The blade control knob (410) may be connected to a linkage (412), which in turn may be connected to the blade (409). The linkage (412) may be configured such that rotation of the control knob (410) in a first direction advances the linkage (412), which in turn rotates the blade (409) from the low-profile configuration to the cutting configuration. Conversely, rotation of the control knob (410) in a second direction may retract the linkage (412), which in turn may rotate the blade (409) from the cutting configuration to the low-profile configuration. While the fistula-forming element (408) is shown in FIG. 4A as being connected to the first arm (402), it should be appreciated that in some instances the fistula-forming element (408) may be connected to the second arm (404), and in other instances both the first arm (402) and the second arm (404) may comprise a fistula-forming element.


As mentioned above, the device (400) may be used to form a fistula. In these variations, the first arm (402) may be introduced into a first blood vessel and the second arm (404) may be introduced into a second blood vessel. The position of the second arm (404) relative to the second arm (402) may be adjusted to reposition the second blood vessel relative to the first blood vessel. When the blood vessels are positioned as desired, the second arm (404) may be fixed relative to the first arm (402) (e.g., by rotating the knob (422)). With the arms set in a fixed relation, the fistula-forming element (408) may be activated to form a fistula. For example, this may comprise rotating the blade (409) relative to the first arm (402) to cut tissue of the first and second blood vessels positioned between the first arm (402) and the second arm (404).


Ulnar Artery Access


In variations where a catheter or other tool is advanced endovascularly into the ulnar artery, access to the ulnar artery may be achieved in any suitable manner. In some variations, the catheter may be advanced along the brachial artery and into the ulnar artery. In some of these methods, the catheter may be introduced into the vasculature via a brachial access site. In some of these methods, the brachial artery may be cannulated with a cannula directed distally in the brachial artery. The cannula may be any suitable size (e.g., about 5 Fr, about 7 Fr, between about 5 Fr and about 7 Fr), and may be introduced into the brachial access site in any suitable manner, for example, using Seldinger technique, a micropuncture set, and/or a cutdown procedure. In other variations, the catheter may be advanced along the brachial artery from an access site upstream of the brachial artery. For example, the catheter may introduced into the vasculature via a femoral artery access site, and may be advanced to the brachial artery therefrom. In some variations, the ulnar artery may be accessed directly. In some of these variations, an ulnar access site may be formed in the ulnar artery (e.g., at a distal location in the wrist or forearm where the ulnar artery is superficially positioned), and a catheter may be advanced in a retrograde fashion through the ulnar access site. In these variations, the ulnar artery may be cannulated as described above. In still other variations, a catheter or other tool may be advanced endovascularly into the ulnar artery through an access site in the radial artery.


The catheter may be advanced into the ulnar artery using one or more visualization techniques (e.g., via fluoroscopy, ultrasound, combinations thereof, or the like). In some variations, the catheter may be advanced over or along a guidewire which may be placed at the target fistula formation site via one or more of the vascular access sites described immediately above.


Deep Ulnar Vein Access


In variations where a catheter or other tool is advanced endovascularly into a deep ulnar vein, access to the deep ulnar vein may be achieved in any suitable manner. In some variations, the catheter is introduced into the vascular site via an access site. A vascular access site may be formed using a micropuncture set, an access needle (e.g., a 18 or 19 gauge access needle), and/or using a surgical cut-down procedure, such that a cannula may be placed in the blood vessel. The venous access site may be in any suitable blood vessel, such as the basilic vein, the cephalic vein, or a brachial vein.


In some variations, the catheter may be advanced to a deep ulnar vein endovascularly along the median cubital vein. For example in some variations, the catheter may be advanced along the basilic vein, into the median cubital vein, and into one of the deep ulnar veins via the perforating branch extending between the median cubital vein and the deep ulnar veins. In instances where the perforating branch extends between the deep ulnar veins and the median antebrachial vein, the catheter may be advanced from the median cubital vein into the median vein, then into one of the deep ulnar veins.


In other variations, the catheter may be advanced to a deep ulnar vein endovascularly along the median cephalic vein. For example, in some variations, the catheter may be advanced into the vasculature through an access site in the cephalic vein, and may be endovascularly advanced from the cephalic vein into the median cephalic vein, and into one of the deep ulnar veins via a perforating branch (to access the perforating branch, it may be necessary to advance the catheter into either the median cubital vein or the median antebrachial vein).


In still other variations, the catheter may be advanced to a deep ulnar vein endovascularly along a brachial vein. For example, in some variations, the catheter may be advanced into the vasculature through an access site in a brachial vein, and may be endovascularly advanced from the brachial vein into one of the deep ulnar veins in a retrograde fashion.


The catheter may be advanced into the deep ulnar vein using one or more visualization techniques (e.g., via fluoroscopy, ultrasound, combinations thereof, or the like). In some variations, the catheter may be advanced over or along a guidewire which may be placed at the target fistula formation site via one or more of the vascular access sites described immediately above.


Dialysis Access


As mentioned above, one or more veins may be cannulated following fistula formation to provide dialysis access. Generally, providing dialysis access comprises cannulating one or more blood vessels with a first needle and a second needle. Generally, one of the needles may be an arterial needle configured to supply blood to a dialysis machine, while the other needle may be a venous needle configured to return blood to the patient. In some variations, both the first and second needles may be placed in the cephalic vein. In other variations, both the first and second needles may be placed in the basilic vein. In still other variations, both the first and second needles may be placed in the median cubital vein. When both the first and second needles are placed in the same vein segment, it may be desirable to place the arterial and venous needles such that they are at least about 5 cm apart, which may reduce the likelihood that blood returned to the patient through the venous needle is taken up by the arterial needle.


In other variations, the first and second needles may be positioned in different blood vessels. In some variations, a first needle may be placed in a basilic vein and a second needle may be placed in a median cubital vein (e.g., an arterial needle may be placed in the median cubital vein and a venous needle may be placed in the basilica vein). In other variations, a first needle may be placed in a cephalic vein and a second needle may be placed in a median cubital vein (e.g., an arterial needle may be placed in the median cubital vein and a venous needle may be placed in the cephalic vein). In still other variations, a first needle may be placed in a cephalic vein and second needle may be placed in a basilic vein (e.g., an arterial needle may be placed in the basilic vein and a venous needle may be placed in the cephalic vein). In these variations, the needle placed in the cephalic vein may be either the arterial needle or the venous needle. When a first needle and second needle are positioned in different blood vessels (e.g., when a first needle is placed in the basilic vein and a second needle is placed in the antecubital vein or the cephalic vein), there may be a reduced likelihood that blood returned to the body via the venous needle (which may be either the first or second needle) may be taken up by the arterial needle.


EXAMPLE 1

A total of nine patients received a percutaneously-formed fistula between a proximal ulnar artery and a deep ulnar vein of an arm of each patient. To form the fistula, a first catheter carrying an electrode was percutaneously positioned in the deep ulnar vein (via brachial vein access) and a second catheter was percutaneously positioned in the proximal ulnar artery (via brachial artery access), and the electrode ablated tissue between the deep ulnar vein and the proximal ulnar artery to remove tissue between the vessels. The arm was immobilized at the wrist during the formation of the fistula. Patient follow-ups occurred at one month, two months, and three months. At the first follow-up, one or more vessels were coil embolized in some patients at the discretion of the physician.


As shown in Table 1, a fistula was successfully formed in nine of nine patients. For the nine patients, the average time to dialysis readiness was 62 days. Dialysis readiness was determined based on successful initiation of dialysis or physical determination of a flow rate of at least 300 ml/min. Nine of the nine patients maintained fistula and vein patency at three months.









TABLE 1







Results from Example 1










Patient Study (9 patients)
Results







Successful fistula formation
100% (9/9)



Average time to dialysis readiness

62 days (n = 9)




Fistula/vein patency at three months
100% (9/9)










EXAMPLE 2

A total of seven patients received a percutaneously-formed fistula between a proximal ulnar artery and a deep ulnar vein of an arm of each patient. To form the fistula, a first catheter carrying an electrode was percutaneously positioned in the deep ulnar vein (via cephalic, basilic, or brachial vein access) and a second catheter was percutaneously positioned in the proximal ulnar artery (via brachial artery access), and the electrode ablated tissue between the proximal ulnar artery and the deep ulnar vein to remove tissue between the vessels. The arm was not immobilized during the formation of the fistula. Patient follow-ups occurred at one, two, and three months. During follow-ups, one or more vessels were coil embolized in some patients at the discretion of the physician. Two patients received balloon angioplasty at three months, and one patient received balloon angioplasty and surgical revision at three months.


As shown in Table 2, a fistula was successfully formed in six of seven patients. Of the six patients with a successfully-formed fistula, each maintained fistula and vein patency at three months. One patient was withdrew from the study after the three-month evaluation. Of the remaining five patients, the average time to dialysis readiness was 108 days. Dialysis readiness was determined based on successful initiation of dialysis or physical determination of a flow rate of at least 300 ml/min.









TABLE 2







Results from Example 2








Patient Study (7 patients)
Results












Successful fistula formation
86%
(6/7)


Average time to dialysis readiness
108 days
(n = 5)


Fistula/vein patency at three months following
100%
(6/6)


successful fistula formation









EXAMPLE 3

A total of eight patients received a percutaneously-formed fistula between a proximal ulnar artery and a deep ulnar vein of an arm of each patient. To form the fistula, a first catheter carrying an electrode was percutaneously positioned in the deep ulnar vein (via brachial vein access) and a second catheter was percutaneously positioned in the proximal ulnar artery (via brachial artery access), and the electrode ablated tissue between the proximal ulnar artery and the deep ulnar vein to remove tissue between the vessels. The arm was immobilized at the wrist during the formation of the fistula. The brachial vein was coil embolized during the procedure. Patient follow-ups occurred at one, two, and three months.


As shown in Table 3, a fistula was successfully formed in all eight patients. One patient died of causes unrelated to the procedure (arrhythmia caused by hyperkalemia) prior to the two-month evaluation. A second patient achieved dialysis readiness, but died of causes unrelated to the procedure (septicemia from diabetic foot ulcer) prior to the three-month evaluation. Of the six patients that received a three-month evaluation, five maintained fistula and vein patency at three months. For the six patients that achieved dialysis readiness, the average time to dialysis readiness was 37 days. Dialysis readiness was determined based on successful initiation of dialysis or physical determination of a flow rate of at least 300 ml/min.









TABLE 3







Results from Example 3










Patient Study (8 patients)
Results















Successful fistula formation
100%
(8/8)



Average time to dialysis readiness
37 days
(n = 6)



Fistula/vein patency at three months
83%
(5/6)









Claims
  • 1. A method for treating a patient comprising: forming an access site in an arm location; andforming a first fistula between a proximal ulnar artery and a first deep ulnar vein, the first deep ulnar vein being substantially parallel to the proximal ulnar artery between a brachial artery and an interosseous artery.
  • 2. The method of claim 1 wherein the arm location is a wrist, forearm, or upper arm.
  • 3. The method of claim 2 wherein the access site is formed in an ulnar artery at the wrist.
  • 4. The method of claim 1 further comprising endovascularly advancing a distal portion of a first catheter through the access site and into an ulnar artery.
  • 5. The method of claim 1 further comprising endovascularly advancing a distal portion of a first catheter into the first deep ulnar vein.
  • 6. The method of claim 5 wherein the first catheter comprises a fistula-forming element, and wherein forming the first fistula between the proximal ulnar artery and the first deep ulnar vein comprises forming the first fistula using the fistula-forming element.
  • 7. The method of claim 6 wherein the fistula-forming element comprises an electrode.
  • 8. The method of claim 7 further comprising moving the electrode away from the first catheter against a vessel wall of the first deep ulnar vein and wherein forming the first fistula between the proximal ulnar artery and the first deep ulnar vein comprises ablating the vessel wall of the first deep ulnar vein and a vessel wall of the proximal ulnar artery.
  • 9. The method of claim 5 further comprising advancing a distal portion of a second catheter into the proximal ulnar artery.
  • 10. The method of claim 9 wherein the first and second catheters each comprise one or more magnets and further comprising aligning the first and second catheters using the one or more magnets of each of the first and second catheters.
  • 11. The method of claim 9 wherein the second catheter comprises a fistula-forming element, and wherein forming the first fistula between the proximal ulnar artery and the first deep ulnar vein comprises forming the first fistula using the fistula-forming element.
  • 12. The method of claim 11 wherein the fistula-forming element comprises an electrode.
  • 13. The method of claim 12 further comprising moving the electrode away from the second catheter against a vessel wall of the proximal ulnar artery, and wherein forming the first fistula between the proximal ulnar artery and the first deep ulnar vein comprises ablating the vessel wall of the proximal ulnar artery and a vessel wall of the first deep ulnar vein.
  • 14. The method of claim 9 wherein endovascularly advancing the distal portion of the second catheter into the proximal ulnar artery comprises endovascularly advancing the distal portion of the second catheter into the proximal ulnar artery from the brachial artery.
  • 15. The method of claim 14 further comprising creating a second access site in the brachial artery and advancing the second catheter into the brachial artery through the second access site.
  • 16. A method for treating a patient comprising: endovascularly advancing a distal portion of a first catheter through a portion of an ulnar vein and into a first deep ulnar vein, the first deep ulnar vein being substantially parallel to an ulnar artery between a brachial artery and an interosseous artery;endovascularly advancing a distal portion of a second catheter through a portion of the brachial artery and into the ulnar artery; andforming a fistula between the first deep ulnar vein and the ulnar artery.
  • 17. A method for treating a patient comprising: endovascularly advancing a distal portion of a first catheter through a portion of a radial artery and into an ulnar artery;endovascularly advancing a distal portion of a second catheter through a portion of a brachial vein and into an ulnar vein; andforming a fistula between a first deep ulnar vein and the ulnar artery, the first deep ulnar vein being substantially parallel to the ulnar artery between the brachial artery and an interosseous artery.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 14/052,477, filed on Oct. 11, 2013, which claims priority to U.S. Provisional Application Ser. No. 61/712,704, filed on Oct. 11, 2012 and titled “DEVICES AND METHODS FOR FISTULA FORMATION,” and to U.S. Provisional Application Ser. No. 61/785,548, filed on Mar. 14, 2013 and titled “DEVICES AND METHODS FOR FISTULA FORMATION,” the contents of which are hereby incorporated by reference in their entirety.

US Referenced Citations (347)
Number Name Date Kind
3649850 Davis Mar 1972 A
3827436 Stumpf et al. Aug 1974 A
4416664 Womack Nov 1983 A
4802475 Weshahy Feb 1989 A
5313943 Houser et al. May 1994 A
5383460 Jang et al. Jan 1995 A
5697909 Eggers et al. Dec 1997 A
5782239 Webster, Jr. Jul 1998 A
5800487 Mikus et al. Sep 1998 A
5830222 Makower Nov 1998 A
5830224 Cohn et al. Nov 1998 A
5836947 Fleischman et al. Nov 1998 A
5895404 Ruiz Apr 1999 A
5971979 Joye et al. Oct 1999 A
6004330 Middleman et al. Dec 1999 A
6032677 Blechman et al. Mar 2000 A
6039730 Rabin et al. Mar 2000 A
6068638 Makower May 2000 A
6071274 Thompson et al. Jun 2000 A
6099542 Cohn et al. Aug 2000 A
6159225 Makower Dec 2000 A
6190353 Makower et al. Feb 2001 B1
6197025 Grossi et al. Mar 2001 B1
6217575 DeVore et al. Apr 2001 B1
6231587 Makower May 2001 B1
6256525 Yang et al. Jul 2001 B1
6283988 Laufer et al. Sep 2001 B1
6287306 Kroll et al. Sep 2001 B1
6302875 Makower et al. Oct 2001 B1
6327505 Medhkour et al. Dec 2001 B1
6347247 Dev et al. Feb 2002 B1
6355029 Joye et al. Mar 2002 B1
6357447 Swanson et al. Mar 2002 B1
6379353 Nichols Apr 2002 B1
6383180 LaLonde et al. May 2002 B1
6394956 Chandrasekaran et al. May 2002 B1
6400976 Champeau Jun 2002 B1
6428534 Joye et al. Aug 2002 B1
6461356 Patterson Oct 2002 B1
6464665 Heuser Oct 2002 B1
6464723 Callol Oct 2002 B1
6468268 Abboud et al. Oct 2002 B1
6475214 Moaddeb Nov 2002 B1
6475226 Belef et al. Nov 2002 B1
6527724 Fenici Mar 2003 B1
6527769 Langberg et al. Mar 2003 B2
6542766 Hall et al. Apr 2003 B2
6544230 Flaherty et al. Apr 2003 B1
6569158 Abboud et al. May 2003 B1
6569162 He May 2003 B2
6579311 Makower Jun 2003 B1
6585650 Solem Jul 2003 B1
6592577 Abboud et al. Jul 2003 B2
6629987 Gambale et al. Oct 2003 B1
6635053 LaLonde et al. Oct 2003 B1
6655386 Makower et al. Dec 2003 B1
6656173 Palermo Dec 2003 B1
6663625 Ormsby et al. Dec 2003 B1
6669709 Cohn et al. Dec 2003 B1
6673085 Berg Jan 2004 B1
6676657 Wood Jan 2004 B2
6682525 LaLonde et al. Jan 2004 B2
6695878 McGuckin et al. Feb 2004 B2
6709444 Makower Mar 2004 B1
6719756 Muntermann Apr 2004 B1
6726697 Nicholas et al. Apr 2004 B2
6733494 Abboud et al. May 2004 B2
6736808 Motamedi et al. May 2004 B1
6761708 Chiu Jul 2004 B1
6761714 Abboud et al. Jul 2004 B2
6780181 Kroll et al. Aug 2004 B2
6849073 Hoey et al. Feb 2005 B2
6855143 Davison et al. Feb 2005 B2
6887234 Abboud et al. May 2005 B2
6911026 Hall et al. Jun 2005 B1
6932814 Wood Aug 2005 B2
6936024 Houser Aug 2005 B1
6960209 Clague et al. Nov 2005 B2
6971983 Cancio Dec 2005 B1
6981972 Farley et al. Jan 2006 B1
7059330 Makower et al. Jun 2006 B1
7060063 Marion et al. Jun 2006 B2
7094235 Francischelli Aug 2006 B2
7155293 Westlund et al. Dec 2006 B2
7179270 Makower Feb 2007 B2
7189231 Clague et al. Mar 2007 B2
7214234 Rapacki et al. May 2007 B2
7231260 Wallace et al. Jun 2007 B2
7250051 Francischelli Jul 2007 B2
7288075 Parihar et al. Oct 2007 B2
7303554 LaLonde et al. Dec 2007 B2
7306598 Truckai et al. Dec 2007 B2
7335198 Eggers et al. Feb 2008 B2
7341063 Garbibaldi et al. Mar 2008 B2
7367341 Anderson et al. May 2008 B2
7374567 Heuser May 2008 B2
7387636 Cohn et al. Jun 2008 B2
7407506 Makower Aug 2008 B2
7522950 Fuimaono et al. Apr 2009 B2
7628768 Faul et al. Dec 2009 B2
7702387 Stevenson et al. Apr 2010 B2
7727268 Cunniffe et al. Jun 2010 B2
7744596 Young et al. Jun 2010 B2
7811281 Rentrop Oct 2010 B1
7828814 Brenneman et al. Nov 2010 B2
7846172 Makower Dec 2010 B2
7849860 Makower et al. Dec 2010 B2
7857809 Drysen Dec 2010 B2
7881797 Griffin et al. Feb 2011 B2
7955326 Paul et al. Jun 2011 B2
7967769 Faul et al. Jun 2011 B2
7967770 Li et al. Jun 2011 B2
8010208 Nimer et al. Aug 2011 B2
8048016 Faul et al. Nov 2011 B2
8052680 Hassett et al. Nov 2011 B2
8062321 Heuser et al. Nov 2011 B2
RE43007 LaLonde et al. Dec 2011 E
8075555 Truckai et al. Dec 2011 B2
8088171 Brenneman Jan 2012 B2
8100899 Doty et al. Jan 2012 B2
8118809 Paul et al. Feb 2012 B2
8135467 Markowitz et al. Mar 2012 B2
8142454 Harrison et al. Mar 2012 B2
8192425 Mirza et al. Jun 2012 B2
8200466 Spilker et al. Jun 2012 B2
8226592 Brenneman et al. Jul 2012 B2
8231618 Viswanathan et al. Jul 2012 B2
8236014 Brenneman et al. Aug 2012 B2
8262649 Francischelli Sep 2012 B2
8273095 Brenneman et al. Sep 2012 B2
8328797 Wilson et al. Dec 2012 B2
8333758 Joye et al. Dec 2012 B2
8361061 Esch et al. Jan 2013 B2
8366707 Kassab et al. Feb 2013 B2
8382697 Brenneman et al. Feb 2013 B2
8409196 Durgin et al. Apr 2013 B2
8413664 Appling Apr 2013 B2
8414572 Davison et al. Apr 2013 B2
8419681 Sell Apr 2013 B2
8439909 Wang et al. May 2013 B2
8454587 LaLonde et al. Jun 2013 B2
8475441 Babkin et al. Jul 2013 B2
8486062 Belhe et al. Jul 2013 B2
8486064 Van Wyk et al. Jul 2013 B2
8551032 Faul et al. Oct 2013 B2
8574185 Faul et al. Nov 2013 B2
8585700 Katou Nov 2013 B2
8608754 Wensel et al. Dec 2013 B2
8641724 Brenneman et al. Feb 2014 B2
8649879 DiGiore et al. Feb 2014 B2
8676309 Deem et al. Mar 2014 B2
8685014 Babkin et al. Apr 2014 B2
8700179 Pianca et al. Apr 2014 B2
8715281 Barlow et al. May 2014 B2
8758334 Coe et al. Jun 2014 B2
8784409 Robilotto et al. Jun 2014 B2
8771267 Kunis et al. Jul 2014 B2
8790341 Pappone et al. Jul 2014 B2
8876699 Sato et al. Nov 2014 B2
8876815 Coe et al. Nov 2014 B2
8882765 Kassab et al. Nov 2014 B2
8911435 Katoh et al. Dec 2014 B2
8951251 Willard Feb 2015 B2
9017323 Miller et al. Apr 2015 B2
9039702 Miller et al. May 2015 B2
9072880 Phillips et al. Jul 2015 B2
9089316 Baust et al. Jul 2015 B2
9108018 Dickinson et al. Aug 2015 B2
9155827 Franano Oct 2015 B2
9204916 Lalonde Dec 2015 B2
9259340 Heuser et al. Feb 2016 B2
9283034 Katoh et al. Mar 2016 B2
9307992 Wilson et al. Apr 2016 B2
9314329 Dickinson et al. Apr 2016 B2
9326792 Dickinson et al. May 2016 B2
9364280 Zarins et al. Jun 2016 B2
9402560 Organ et al. Aug 2016 B2
9414885 Willard Aug 2016 B2
9439728 Hull et al. Sep 2016 B2
9445868 Hull et al. Sep 2016 B2
9452015 Kellerman et al. Sep 2016 B2
9486276 Rios Nov 2016 B2
9510901 Steinke et al. Dec 2016 B2
9623217 Pillai Apr 2017 B2
9706998 Dickinson et al. Jul 2017 B2
9782201 Dickinson et al. Oct 2017 B2
9782533 Brenneman et al. Oct 2017 B2
10045817 Miller et al. Aug 2018 B2
10265206 Heuser et al. Apr 2019 B2
10517637 Dickinson et al. Dec 2019 B2
10543308 Lenihan et al. Jan 2020 B2
10575974 De Pablo et al. Mar 2020 B2
10596356 Lenihan et al. Mar 2020 B2
20010029384 Nicholas et al. Oct 2001 A1
20020072739 Lee et al. Jun 2002 A1
20020113678 Creighton Aug 2002 A1
20020151945 Gobin et al. Oct 2002 A1
20030009163 Messing et al. Jan 2003 A1
20030220674 Anderson et al. Nov 2003 A1
20040059211 Patel et al. Mar 2004 A1
20040059280 Makower et al. Mar 2004 A1
20040167506 Chen Aug 2004 A1
20040215220 Dolan et al. Oct 2004 A1
20040236360 Cohn et al. Nov 2004 A1
20050033401 Cunniffe et al. Feb 2005 A1
20050065509 Coldwell et al. Mar 2005 A1
20050245925 Iki et al. Nov 2005 A1
20050251120 Anderson et al. Nov 2005 A1
20060079897 Harrison et al. Apr 2006 A1
20060111704 Brenneman et al. May 2006 A1
20070173878 Heuser Jul 2007 A1
20070185567 Heuser et al. Aug 2007 A1
20070203515 Heuser et al. Aug 2007 A1
20070203572 Heuser et al. Aug 2007 A1
20080021532 Kveen et al. Jan 2008 A1
20080051626 Sato et al. Feb 2008 A1
20080065019 Heuser et al. Mar 2008 A1
20080091192 Paul et al. Apr 2008 A1
20080119879 Brenneman et al. May 2008 A1
20080140061 Toubia et al. Jun 2008 A1
20080161901 Heuser et al. Jul 2008 A1
20080171944 Brenneman et al. Jul 2008 A1
20080183164 Elkins et al. Jul 2008 A1
20080188848 Deutmeyer et al. Aug 2008 A1
20080221519 Schwach et al. Sep 2008 A1
20080275442 Paul et al. Nov 2008 A1
20080312577 Drasler et al. Dec 2008 A1
20090036872 Fitzgerald et al. Feb 2009 A1
20090076324 Takayama et al. Mar 2009 A1
20090112119 Kim Apr 2009 A1
20090118722 Ebbers et al. May 2009 A1
20090124847 Doty et al. May 2009 A1
20090187098 Makower et al. Jul 2009 A1
20090198232 Young et al. Aug 2009 A1
20090248148 Shaolian et al. Oct 2009 A1
20090275876 Brenneman et al. Nov 2009 A1
20090281379 Binmoeller et al. Nov 2009 A1
20090318849 Hobbs et al. Dec 2009 A1
20100004623 Hamilton, Jr. et al. Jan 2010 A1
20100010488 Kassab et al. Jan 2010 A1
20100082058 Kassab Apr 2010 A1
20100130835 Brenneman et al. May 2010 A1
20100198206 Levin Aug 2010 A1
20100204691 Bencini Aug 2010 A1
20100222664 Lemon et al. Sep 2010 A1
20100256616 Katoh et al. Oct 2010 A1
20100280316 Deitz et al. Nov 2010 A1
20100280514 Zerfas et al. Nov 2010 A1
20100286705 Vassiliades, Jr. Nov 2010 A1
20100292685 Katoh et al. Nov 2010 A1
20100298645 Deutch Nov 2010 A1
20110015657 Brenneman et al. Jan 2011 A1
20110112427 Phillips et al. May 2011 A1
20110118735 Abou-Marie et al. May 2011 A1
20110201990 Franano Aug 2011 A1
20110213309 Young et al. Sep 2011 A1
20110218476 Kraemer et al. Sep 2011 A1
20110270149 Faul et al. Nov 2011 A1
20110288392 de la Rama et al. Nov 2011 A1
20110288544 Verin et al. Nov 2011 A1
20110306959 Kellerman et al. Dec 2011 A1
20110306993 Hull et al. Dec 2011 A1
20110319976 Iyer et al. Dec 2011 A1
20120010556 Faul et al. Jan 2012 A1
20120022518 Levinson Jan 2012 A1
20120035539 Tegg Feb 2012 A1
20120046678 LeMaitre et al. Feb 2012 A1
20120059398 Pate et al. Mar 2012 A1
20120065652 Cully et al. Mar 2012 A1
20120078342 Vollkron et al. Mar 2012 A1
20120089123 Organ et al. Apr 2012 A1
20120101423 Brenneman Apr 2012 A1
20120116354 Heuser May 2012 A1
20120157992 Smith et al. Jun 2012 A1
20120209377 Machold et al. Aug 2012 A1
20120215088 Wang et al. Aug 2012 A1
20120239021 Doty et al. Sep 2012 A1
20120277736 Francischelli Nov 2012 A1
20120281330 Abbott et al. Nov 2012 A1
20120289953 Berzak et al. Nov 2012 A1
20120296262 Ogata et al. Nov 2012 A1
20120302935 Miller et al. Nov 2012 A1
20130041306 Faul et al. Feb 2013 A1
20130056876 Harvey et al. Mar 2013 A1
20130110105 Vankov May 2013 A1
20130172881 Hill et al. Jul 2013 A1
20130190744 Avram et al. Jul 2013 A1
20130190754 Paul et al. Jul 2013 A1
20130216351 Griffin Aug 2013 A1
20130226170 Seddon et al. Aug 2013 A1
20130261368 Schwartz Oct 2013 A1
20130282000 Parsonage Oct 2013 A1
20130296704 Magnin et al. Nov 2013 A1
20140012251 Himmelstein et al. Jan 2014 A1
20140031674 Newman et al. Jan 2014 A1
20140094791 Hull et al. Apr 2014 A1
20140100557 Bohner et al. Apr 2014 A1
20140100562 Sutermeister et al. Apr 2014 A1
20140107642 Rios et al. Apr 2014 A1
20140166098 Kian et al. Jun 2014 A1
20140188028 Brenneman et al. Jul 2014 A1
20140276335 Pate Sep 2014 A1
20150005759 Welches et al. Jan 2015 A1
20150011909 Holmin et al. Jan 2015 A1
20150018810 Baust et al. Jan 2015 A1
20150057654 Leung et al. Feb 2015 A1
20150057687 Gittard et al. Feb 2015 A1
20150080886 Miller et al. Mar 2015 A1
20150094645 Omar-Pasha Apr 2015 A1
20150112195 Berger et al. Apr 2015 A1
20150134055 Spence et al. May 2015 A1
20150141836 Naumann et al. May 2015 A1
20150164573 Delaney Jun 2015 A1
20150196309 Matsubara et al. Jul 2015 A1
20150196356 Kauphusman et al. Jul 2015 A1
20150196360 Grantham et al. Jul 2015 A1
20150201962 Kellerman et al. Jul 2015 A1
20150258308 Pate Sep 2015 A1
20150297259 Matsubara et al. Oct 2015 A1
20150313668 Miller et al. Nov 2015 A1
20150320472 Ghaffari et al. Nov 2015 A1
20160022345 Baust et al. Jan 2016 A1
20160051323 Stigall et al. Feb 2016 A1
20160058452 Brenneman et al. Mar 2016 A1
20160058956 Cohn et al. Mar 2016 A1
20160067449 Misener et al. Mar 2016 A1
20160082234 Schwartz et al. Mar 2016 A1
20160100840 Brenneman et al. Apr 2016 A1
20160128855 Heuser et al. May 2016 A1
20160135881 Katoh et al. May 2016 A1
20160184011 Krishnan Jun 2016 A1
20160206317 Dickinson et al. Jul 2016 A1
20170071627 Kellerman et al. Mar 2017 A1
20170119464 Rios et al. May 2017 A1
20170172679 Doty et al. Jun 2017 A1
20170202603 Cohn et al. Jul 2017 A1
20170202616 Pate et al. Jul 2017 A1
20170232272 Perkins et al. Aug 2017 A1
20170252006 Tsuruno Sep 2017 A1
20180000512 Dickinson et al. Jan 2018 A1
20180083228 Yang et al. Mar 2018 A1
20180116522 Brenneman et al. May 2018 A1
20180206845 Brenneman et al. Jul 2018 A1
20180344396 Miller et al. Dec 2018 A1
20200038103 Pappone et al. Feb 2020 A1
20200061338 Pate Feb 2020 A1
20200178970 Berman et al. Jun 2020 A1
Foreign Referenced Citations (49)
Number Date Country
2883209 Apr 2014 CA
1730123 Feb 2006 CN
101730557 Jun 2010 CN
101730557 Jun 2010 CN
0 889 705 Jan 1999 EP
0923912 Jun 1999 EP
H-11-512640 Nov 1999 JP
2004-501720 Jan 2004 JP
3493464 Feb 2004 JP
2006-181370 Jul 2006 JP
2168951 Jun 2001 RU
2168951 Jun 2001 RU
WO-9713463 Apr 1997 WO
9729682 Aug 1997 WO
WO-9733522 Sep 1997 WO
WO 9956640 Nov 1999 WO
WO-0202163 Jan 2002 WO
WO-0202163 Jan 2002 WO
2008010039 Jan 2008 WO
2009005644 Jan 2009 WO
WO-2009005644 Jan 2009 WO
WO-2009005644 Jan 2009 WO
2011100625 Aug 2011 WO
WO-2011100625 Aug 2011 WO
WO-2011100625 Aug 2011 WO
2012015722 Feb 2012 WO
WO-2012068273 May 2012 WO
2013112584 Aug 2013 WO
2014028306 Feb 2014 WO
2014052919 Apr 2014 WO
WO-2014052919 Apr 2014 WO
WO-2014059351 Apr 2014 WO
WO-2014137830 Sep 2014 WO
WO-2014153229 Sep 2014 WO
WO-2015040557 Mar 2015 WO
2015061614 Apr 2015 WO
WO-2015061614 Apr 2015 WO
2015085119 Jun 2015 WO
WO-2015085119 Jun 2015 WO
2015108984 Jul 2015 WO
2015138998 Sep 2015 WO
WO-2015138998 Sep 2015 WO
WO-2016033374 Mar 2016 WO
WO-2016033380 Mar 2016 WO
2016081321 May 2016 WO
WO-2017124059 Jul 2017 WO
WO-2017124060 Jul 2017 WO
WO-2017124062 Jul 2017 WO
2018057095 Mar 2018 WO
Non-Patent Literature Citations (39)
Entry
International Search Report and Written Opinion dated Mar. 31, 2017, for PCT Patent Application No. PCT/US17/13611, filed on Jan. 15, 2017, 10 pages.
Non-Final Office Action dated Apr. 13, 2017, for U.S. Appl. No. 14/697,451, filed Apr. 27, 2015, 14 pages.
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee dated Mar. 31, 2017, for PCT Application No. PCT/US17/13613, filed Jan. 15, 2017, 3 pages.
International Search Report and Written Opinion dated Jun. 1, 2017, for PCT Patent Application No. PCT/US2017/13613, filed Jan. 15, 2017, 18 pages.
Non-Final Office Action dated Jul. 10, 2017, for U.S. Appl. No. 14/214,503, filed Mar. 14, 2014, 11 pages.
International Search Report and Written Opinion dated Jan. 6, 2016, from the International Searching Authority for Application No. PCT/US2015/047274, filed Aug. 27, 2015, 12 pages.
Invitation to Pay Additional Fees and, where Applicable, Protest Fee issued by the International Searching Authority for Application No. PCT/US2015/047274, filed Aug. 27, 2015, dated Oct. 22, 2015, 2 pages.
International Search Report and Written Opinion dated May 19, 2017, by the International Searching Authority for Application No. PCT/US2017/013610, filed Jan. 15, 2017, 10 pages.
Banasik et al. (2011). “A rare variant route of the ulnar artery does not contraindicate the creation of a fistula in the wrist of a diabetic patient with end-stage renal disease,” Postepy Hig Med Dosw. 65:654-657.
Bharat et al. (2012). “A novel technique of vascular anastomosis to prevent juxta-anastomotic stenosis following arteriovenous fistula creation,” J. Vascular Surgery 55(1):274-280.
Bode et al. (2011). “Clinical study protocol for the arch project Computational modeling for improvement of outcome after vascular access creation,” J. Vasc. Access 12(4):369-376.
Davidson, I. et al. (2008). “Duplex Ultrasound Evaluation for Dialysis Access Selection and Maintenance: A Practical Guide,” The Journal of Vascular Access 9(1):1-9.
Extended European Search Report dated Oct. 19, 2016, for EP Application No. 14 770 396.1, filed on Mar. 14, 2014, 7 pages.
Final Office Action dated Mar. 10, 2016, for U.S. Appl. No. 14/052,477, filed Oct. 11, 2013, 11 pages.
Final Office Action dated Oct. 6, 2016, for U.S. Appl. No. 14/697,451, filed Apr. 27, 2015, 11 pages.
Gracz, et al. (1977). “Proximal forearm fistula for maintenance hemodialysis,” Kidney International 11:71-75.
International Search Report and Written Opinion dated Feb. 23, 2012, for PCT Patent Application No. PCT/US2011/061026, filed on Nov. 16, 2011, 8 pages.
International Search Report and Written Opinion dated Jan. 10, 2014, for PCT Patent Application No. PCT/US2013/064657, filed on Oct. 11, 2013, 9 pages.
International Search Report and Written Opinion dated Aug. 22, 2014, for PCT Patent Application No. PCT/US2014/029731, filed on Mar. 14, 2014, 12 pages.
International Search Report and Written Opinion dated Jun. 17, 2015, for PCT Patent Application No. PCT/US2015/020604, filed on Mar. 13, 2015, 8 pages.
Jennings, W.C. et al. (2011). “Primary arteriovenous fistula inflow proximalization for patients at high risk for dialysis access-associated ischemic steal syndrome,” J. Vasc. Surgery 54(2):554-558.
Kinnaert, et al. (1971). “Ulnar Arteriovenous Fistula for Maintenance Haemodialysis,” British J. Surgery 58(9):641-643.
Morale et al. (2011). “Venae comitantes as a potential vascular resource to create native arteriovenous fistulae,” J. Vasc. Access 12(3):211-214.
Non-Final Office Action dated May 2, 2016, for U.S. Appl. No. 14/697,451, filed Apr. 27, 2015, 12 pages.
Non-Final Office Action dated Aug. 8, 2014, for U.S. Appl. No. 13/298,169, filed Nov. 16, 2011, 15 pages.
Non-Final Office Action dated Jul. 29, 2015, for U.S. Appl. No. 14/052,477, filed Oct. 11, 2013, 15 pages.
Notice of Allowance dated Dec. 31, 2014, for U.S. Appl. No. 13/298,169, filed Nov. 16, 2011, 10 pages.
Notice of Allowance dated Mar. 11, 2015, for U.S. Appl. No. 13/298,169, filed Nov. 16, 2011, 4 pages.
Notice of Allowance dated Jan. 23, 2015, for U.S. Appl. No. 14/550,747, filed Nov. 21, 2014, 10 pages.
Notice of Allowance dated Jul. 12, 2016, for U.S. Appl. No. 14/052,477, filed Oct. 11, 2013, 7 pages.
Shenoy, S. (2009). “Surgical anatomy of upper arm: what is needed for AVF planning,” The Journal of Vascular Access 10:223-232.
Vachharajani, T. (2010). “Atlas of Dialysis Vascular Access,” Wake Forest University School of Medicine, 77 total pages.
Whittaker et al. (2011). “Prevention better than cure. Avoiding steal syndrome with proximal radial or ulnar arteriovenous fistulae,” J. Vasc. Access 12(4):318-320.
Extended European Search Report for EP Application No. 17739123.2.
Maybury et al., “The Effect of Roll Angle on the Performance of Halbach Arrays,” University of California-San Diego, Center for Magnetic Recording Research (2008), 19 pgs.
Choi, et al., Design of a Halbach Magnet Array Based on Optimization Techniques; IEEE Transactions on Magnetics, vol. 44, No. 10, Oct. 2008, pp. 2361-2366. (Year: 2008).
Hakim et al., “Ulnar artery-based free forearm flap: Review of Specific anatomic features in 322 cases and related literature,” Heand & Neck, Dec. 2013 (published online:2014), Wiley Online Library.
Extended European Search Report pertaining to EP Patent Application No. 17853586.0, dated Apr. 29, 2020.
International Search Report and Written Opinion pertaining to PCT/US2019/034896, dated May 12, 2020.
Related Publications (1)
Number Date Country
20170119464 A1 May 2017 US
Provisional Applications (2)
Number Date Country
61712704 Oct 2012 US
61785548 Mar 2013 US
Continuations (1)
Number Date Country
Parent 14052477 Oct 2013 US
Child 15344332 US